Dec 09
2025 has been a landmark year for the Nallathamby Laboratory. From securing major federal funding to advancing our intellectual property and celebrating student milestones, our team has made significant strides in nanomedicine and precision health. Here is a look back at our key achievements. Protecting Our Innovations: Three New Patent Applications It has been a …
Dec 06
Aggressive malignancies like triple-negative breast cancer (TNBC), ovarian cancer, and prostate cancer remain difficult to treat because they often lack the surface receptors required for traditional targeted therapies. Standard treatments like doxorubicin (Dox) are effective at killing cancer but cause severe systemic side effects, most notably cardiotoxicity. To overcome these barriers, the Nallathamby Lab at …
Nov 13
A huge congratulations to Aurelie Brownsberger for passing her qualifying exam on November 12, 2025! This major milestone marks her official transition to PhD Candidate in the Department of Aerospace and Mechanical Engineering. Aurelie’s work is at the cutting edge of precision medicine. She is engineering “smart” nanoparticles (Dox-MagSiNs) that act as trojan horses for …
Sep 05
We are excited to announce support for the Health Data and Analytics Challenge (HDAC), a forward-thinking initiative designed to harness the power of data to solve pressing real-world health issues. Building on the success of the 2024 Health Equity Data Science Challenge, HDAC is set to become an annual event that amplifies the University’s Bioengineering …
Aug 15
The Nallathamby Lab is proud to welcome Carlie Kudary as a PhD student in Bioengineering (Civil Engineering Environmental Earth Sciences) this Fall 2025. Carlie transitions into this role with a wealth of experience, having previously served as a technician for the Berthiaume Institute for Precision Health (BIPH). In that capacity, she played a key role …
Aug 03
I am pleased to announce that our abstract (ID # MHSRS-25-16717) has been accepted for a poster presentation at the 2025 Military Health System Research Symposium (MHSRS) in Kissimmee, Florida. We will be presenting during Poster Session 1 on Tuesday, August 5, 2025, under the breakout session “Old Antibiotics, New Strategies: Repurposing & Combining FDA-Approved …
Aug 01
We are incredibly proud to announce that two exceptional alumni of our research group, Kevin Armknecht and Conor Sheehan, are embarking on their next chapter as medical students this summer. Both Kevin and Conor have been instrumental to our work on antimicrobial nanotechnologies, and their acceptance into medical school is a testament to their dedication, …
Jul 23
Please join me in congratulating Olivia Sayani for winning First Place in the 2025 Summer Undergraduate 3-Minute Thesis (3MT) Competition at the University of Notre Dame! 🏆🎤In just three minutes, Olivia distilled complex research into a crisp, compelling narrative—showcasing her talent not only as a promising scientist but also as a gifted science communicator. Her …
Jul 18
I recently returned from Washington, D.C., where I had the privilege of attending the 2025 MTEC Defense Medical Innovation Summit. Hosted at Venable LLP, the two-day event was a powerhouse of collaboration, bringing together the sharpest minds from the Defense Health Agency (DHA), DARPA, and private industry to map out the future of military medicine. …
May 22
I am pleased to announce that our lab has been awarded a new grant from the Congressionally Directed Medical Research Programs (CDMRP) – Peer Reviewed Cancer Research Program (PRCRP). Running from 2025 to 2027, this project (Award No. HT94252510332) is titled “Multispecific Bridge Nanoparticles to Engage T Cells and Off-the-Shelf CAR-T Cells Against Antigen(+) EC …
NIH Funding Opportunities
Recent Comments